Oncolytic adenoviruses expressing monoclonal antibody trastuzumab for treatment of Her-2+ cancer

Project Information

TRASTUZUCRAD

Grant agreement ID: 201667

Project closed

Start date 1 September 2008

End date 31 August 2014

Funded under

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost

€ 1 622 360,00

EU contribution

€ 1 622 360,00

Coordinated by

HELSINGIN YLIOPISTO
Finland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .